Strategic planning of a telepharmaceutical care service for patients with asthma: an implementation study
DOI:
https://doi.org/10.30968/rbfhss.2021.123.0654Abstract
Objective: To describe the implementation process of the Tele-Pharmaceutical Care pilot program, as a tool to promote adherence to treatment for asthma. Methods: In planning, situational strategic planning theory and adapted design thinking were used to develop the intervention instrument. A questionnaire was designed to guide the Telepharmaceutical care, which included the asthma control score and the Brief Medication Questionnaire. The planning began in February 2020 and treatment took place from March to May 2020. The sample was non-probabilistic and included elderly with asthma registered at the Drug Pharmacy of Rio Grande do Sul, located in the city of Porto Alegre. The McNemar statistical test was used to compare asthma control results at time 0 (pre-intervention) and after the TelePharmaceutical Care intervention. Results: The description of the implementation process provided a mechanism that benefited people for the applicability of this type of service in other scenarios, highlighting the professional pharmacist acting as a teleconsultant, working in remote care for people with chronic respiratory diseases. In the pilot test, 20 patients were seen, who received a second consultation within a period of 3 months. Of the total sample, 70% were women and the general average age was 71 years (± 8 years). The average telephone call time in minutes in the first consultation was 22.4 (± 11.4) and in the second consultation was 17.9 (± 6.7). A statistical analysis by McNemar indicates an increase in the category of belonging to the “good control” category between time zero and after the Tele-Pharmaceutical Care intervention (p = 0.016). Conclusion: Through this action on a pilot scale, it was possible to start the implementation of Tele-Pharmaceutical Care in RS in a planned and coordinated manner, standardizing the work process and suggesting potential to improve the quality of life of patients.
Downloads
Downloads
Additional Files
Published
How to Cite
Issue
Section
License
Copyright (c) 2021 Authors
This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.
The authors hereby transfer, assign, or otherwise convey to RBFHSS: (1) the right to grant permission to republish or reprint the stated material, in whole or in part, without a fee; (2) the right to print republish copies for free distribution or sale; and (3) the right to republish the stated material in any format (electronic or printed). In addition, the undersigned affirms that the article described above has not previously been published, in whole or part, is not subject to copyright or other rights except by the author(s), and has not been submitted for publication elsewhere, except as communicated in writing to RHFHSS with this document.
Authors retain copyright and grant the journal right of first publication with the work simultaneously licensed under a Creative Commons Attribution License (CC-BY-NC-ND) that allows others to share the work with an acknowledgement of the work's authorship and initial publication in this journal.
Serlf-archiving policy
This journal permits and encourages authors to post and archive the final pdf of the articles submitted to the journal on personal websites or institutional repositories after publication, while providing bibliographic details that credit its publication in this journal.
